Status:
UNKNOWN
Efficacy and Safety Study of Egg Yolk Antibody in Adjuvant Treatment of Helicobacter Pylori Infection
Lead Sponsor:
The Third Xiangya Hospital of Central South University
Conditions:
Helicobacter Pylori Infection
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
Helicobacter pylori is an important pathogenic factor for gastrointestinal diseases such as gastritis, peptic ulcer, gastric mucosa-associated lymphoid tissue lymphoma and gastric cancer.However, with...
Detailed Description
Background: Helicobacter pylori is an important pathogenic factor for gastrointestinal diseases such as gastritis, peptic ulcer, gastric mucosa-associated lymphoid tissue lymphoma and gastric cancer.H...
Eligibility Criteria
Inclusion
- Age 18 to 70 years old, male or female;
- Patients diagnosed with Hp infection;
- Failure of Hp eradication therapy;
- Although taking acid-suppressing drugs (PPI), the drug has been stopped for more than 2 weeks;
- Those who have not used antibiotics and (or) bismuth in the past 4 weeks;
- Understand and be willing to participate in this clinical trial and provide signed informed consent.
Exclusion
- Those with a history of allergy to drugs and egg yolk antibody products;
- Those with severe heart, liver, lung and kidney insufficiency;
- Those with a recent history of gastrointestinal bleeding, obstruction, perforation, tumor, and other serious organic diseases of the gastrointestinal tract;
- Those with mental illness or mental disorder that cannot be expressed normally;
- During the research period, those who are pregnant, breastfeeding, or have a childbearing plan recently;
- There are other persons who are not suitable for clinical trials of drugs
- No collaborators.
Key Trial Info
Start Date :
April 6 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2022
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT05410223
Start Date
April 6 2021
End Date
December 1 2022
Last Update
December 9 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Third Xiangya Hospital of Central South University
Changsha, Hunan, China, 410013